Press release
Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/162
Key Takeaways:
The biosimilars market has been experiencing significant growth in recent years. Biosimilars are highly similar versions of approved biologic drugs, offering comparable safety, efficacy, and quality to the reference products.
The primary driving factors behind the biosimilars market growth include the expiry of patents for several biologic drugs, increasing healthcare costs, and the need for affordable treatment options.
Biosimilars provide an opportunity for cost savings and improved access to essential therapies. They can potentially reduce healthcare expenditures by offering lower-priced alternatives to expensive biologics.
Regulatory frameworks have been established in various countries to ensure the safety and efficacy of biosimilars. These frameworks include stringent comparability studies and clinical trials to demonstrate biosimilarity to the reference product.
Market Drivers:
Patent Expirations: The expiration of patents for reference biologic drugs creates opportunities for biosimilar manufacturers to enter the market and offer more affordable alternatives.
Cost Savings: Biosimilars provide cost savings compared to their reference biologic drugs. As healthcare costs continue to rise, payers and healthcare providers are increasingly seeking cost-effective treatment options, driving the demand for biosimilars.
Increasing Demand for Biologics: Biologic drugs have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and chronic conditions. The increasing demand for these therapies creates a significant market opportunity for biosimilars.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/162
Competitive Landscape:
Pfizer Inc.
Novartis AG (Sandoz)
Amgen Inc.
Biocon Ltd.
Celltrion Inc.
Samsung Bioepis Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Fresenius Kabi AG
Dr. Reddy's Laboratories Ltd.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/162
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Sperm Bank Market https://www.alliedmarketresearch.com/sperm-bank-market-A10372
Cancer Diagnostics Market https://www.alliedmarketresearch.com/cancer-diagnostics-market-A11336
Psoriatic Arthritis Treatment Market https://www.alliedmarketresearch.com/psoriatic-arthritis-treatment-market-A05951
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report here
News-ID: 3085158 • Views: …
More Releases from Allied Market Research
IP Video Surveillance and VSaaS Market Competitive Dynamics & Global Outlook -20 …
Allied Market Research published an exclusive report, titled, "IP Video Surveillance and VSaaS Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type and Application - Global Opportunity Analysis and Industry Forecast, 2021-2030".
The global IP video surveillance and VSaaS market size was valued at $28.39 billion in 2020, and is projected to reach $83.03 billion by 2030, growing at a CAGR of 10.9% from 2021 to 2030.
Download Research…
Rapid Expansion Forecasted: Law Enforcement Software Market to Reach $30.6 Billi …
According to the report published by Allied Market Research, the global law enforcement software market size amassed revenue of $13.6 billion in 2021, and is expected to hit $30.6 billion by 2031, registering a CAGR of 8.5% from 2022 to 2031.
The market research study provides a detailed analysis of changing industry trends, top-most segments, value chain analysis, key investment business scenarios, regional space, and competitive space. The study is a…
Nondestructive Testing Equipment Market 2032 Detailed Analysis Focusing on Appli …
Allied Market Research published an exclusive report, titled, "Nondestructive Testing Equipment Market Size, Share, Competitive Landscape and Trend Analysis Report by Testing Method, by Technique, by Industry Vertical : Global Opportunity Analysis and Industry Forecast, 2020-2030".
The nondestructive testing equipment market size was valued at $3.55 Billion in 2020, and is projected to reach $8.12 billion by 2030, registering a CAGR of 8.7% from 2021 to 2030.
Download Research Report Sample &…
Mobile Marketing Market: Trends, Insights, and Strategies for Success 2030
According to the report published by Allied Market Research, the global mobile marketing market generated $11.00 billion in 2020, and is predicted to reach $57.85 billion by 2030, exhibiting a CAGR of 18.3% from 2021 to 2030. The report offers an in-depth analysis of the market size, emerging and current trends, future estimations, and key players.
Mobile marketing is a multi-channel online marketing technique focused on contacting a specific audience on…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
